Acuta Capital Fund, LP is 10% Owner at CAS MEDICAL SYSTEMS INC (CASM). They have made 20 open-market trades across 2 companies since 2017, most recently 2018-03-19.
CIK 0001601391
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
20 open-market purchases totalling $6.1M since 2017, never a sale. Across 20 scored buys the stock is up 52.0% at ninety days, and 46.3 points ahead of the S&P over the same stretch.
20 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +26.5% | +34.6% | +52.0% |
| Alpha | +23.6% | +32.4% | +46.3% |
| Scored | 20 | 20 | 20 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CASM | BUY | 2017-12-27 | 2018-05-01 | $1.00 | $104K | +13.0% | +39.1% | +70.5% |
| IRIX | BUY | 2017-08-16 | 2018-05-01 | $8.42 | $25K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-08-09 | 2018-05-01 | $8.60 | $84K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-08-08 | 2018-05-01 | $8.18 | $108K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-08-04 | 2018-05-01 | $8.18 | $134K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-08-01 | 2018-05-01 | $9.14 | $74K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-28 | 2018-05-01 | $9.50 | $82K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-27 | 2018-05-01 | $9.47 | $70K | +32.3% | +32.7% | +44.1% |
| CASM | BUY | 2017-07-26 | 2018-05-01 | $1.20 | $71K | +13.0% | +39.1% | +70.5% |
| CASM | BUY | 2017-07-25 | 2018-05-01 | $1.03 | $388K | +13.0% | +39.1% | +70.5% |
| IRIX | BUY | 2017-07-21 | 2018-05-01 | $9.54 | $67K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-12 | 2018-05-01 | $9.36 | $91K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-11 | 2018-05-01 | $9.53 | $148K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-10 | 2018-05-01 | $9.61 | $67K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-07 | 2018-05-01 | $9.62 | $79K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-06 | 2018-05-01 | $9.53 | $168K | +32.3% | +32.7% | +44.1% |
| IRIX | BUY | 2017-07-03 | 2018-05-01 | $9.14 | $3.1M | +32.3% | +32.7% | +44.1% |
| CASM | BUY | 2017-03-08 | 2018-05-01 | $1.16 | $780K | +13.0% | +39.1% | +70.5% |
| CASM | BUY | 2017-01-19 | 2018-05-01 | $1.60 | $62K | +13.0% | +39.1% | +70.5% |
| CASM | BUY | 2017-01-04 | 2018-05-01 | $1.57 | $372K | +13.0% | +39.1% | +70.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.